Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of GW870086X in Mild to Moderate Asthma
NCT00945932Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of GW870086 in asthma, sponsored by GSK. Started Jul 2009; status: completed.
02
Drugs
GW870086
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00945932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945932.